The Committee on Legal Affairs and Human Rights discussed challenges related to drug policy and stressed the need of complying with human rights norms and standards.
This paper discusses the need to ensure the drug-use-as-a-health-issue discourse does not side-line the racism and stigma embedded in drug policy and its implementation.
This annual national report by Public Health England describes trends in infections and associated risks and behaviours amongst people who use drugs in the United Kingdom.
The United Nations Office on Drugs and Crime analyses socio‐economic differences between villages that cultivate opium‐poppy and villages that do not in order to evaluate their status and living conditions.
The Eurasian Harm Reduction Association analyses the many challenges faced in sustaining HIV prevention programmes as a result of the Global Fund's withdrawal.
The European Monitoring Centre for Drugs and Drug Addiction has published an update on the size of European illicit drug markets for cannabis, cocaine, MDMA, amphetamines and opioids.
The ACT's pill testing trial identified seven substances containing a potentially dangerous substance, and reported positive implications among the participants' trust in health providers and harm reduction knowledge.
Rights Reporter Foundation's survey of former NSP clients highlight the importance of tailored harm reduction services and addressing socio-structural barriers to health.
This publication examines the nature of the debate surrounding pill-testing in New South Wales, Australia, and calls for a more 'civilised' mode of discussion that is focused on matters of concern.
